Summit Healthcare Acquisition Corp. Blog | Talkmarkets | Page 1
No data available
No data available

Latest Posts

About This Stock More About This Stock
Week In Review: YishengBio To List On NASDAQ Via SPAC Merger At An $834 Million Value
Article By: ChinaBio® Today
Saturday, October 1, 2022 2:40 PM EST
Beijing YishengBio will merge with a SPAC vehicle, Summit Healthcare Acquisition, to list on the NASDAQ Exchange at a pre-money equity value of $834 million. The merger is expected to provide up to $230 million in cash to YishengBio.
In this article: SMIH Also: SGEN, ZLAB, 2142.HK, 3692.HK, 2096.HK, 0460.HK

Latest Tweets for $SMIH

No tweets yet!